To reveal how cultural attitudes toward longevity shape public expectations and present new research on these perceptions, inviting delegates to contribute live to an ongoing study.
In partnership with
With our first speakers officially announced and many more on the way, early bird tickets are now available! Here’s a glimpse of what is in store on the Scaling Health and Longevity Conference agenda.
To reveal how cultural attitudes toward longevity shape public expectations and present new research on these perceptions, inviting delegates to contribute live to an ongoing study.
Longevity has never had more attention, yet most clinics and vendors are struggling to fill chairs. The space looks like a boom, but the boom is in supply, not in working demand. Thousands of providers, vendors, and doctors are now competing for the same individual cash-paying consumer, inside a market that is fragmented, hard to access, and missing the standards and education that large-scale adoption requires.
This opening keynote reframes the challenge every longevity business is facing. The bottleneck is not consumer interest. It is fragmentation, scalability, and trust. Jonathan Edelheit looks at why market confusion and a lack of education freeze buyers, why the race to differentiate is a symptom rather than a cure, and why the biggest growth ahead lies with enterprise: employers, corporations, insurance companies, and banks. He explains why the market has not yet been built to serve those clients, and how the businesses that solve it will grow fast in the decade ahead.
As populations age, most health systems are still built to treat sickness not protect health. This session explores how to redesign care models around early screening, multi‑generational prevention and long term support from prenatal years through to end of life. Leaders from public systems, private providers and insurers will share practical blueprints for shifting resources upstream, integrating data and aligning incentives so that staying healthy becomes the core business of healthcare.
As prevention and early intervention move centre stage, organisations are under pressure to make them both clinically effective and financially sustainable. This session explores how clinics, insurers and employers are redesigning products, incentives and service models to monetise better long‑term health, align economics with prevention, and capture value through reduced risk, improved productivity and stronger member or employee engagement.
GLP‑1 drugs have surged as weight‑loss treatments, but their broader impact on metabolic health, cardiovascular risk and system-wide costs is still emerging. This session explores what GLP‑1s agonists could mean for clinical practice, insurers, employers and consumers, and how these therapies might fit into wider prevention and care strategies as evidence and appetite builds.
As people live longer, traditional models of insurance, pensions and savings face growing strain and no longer map neatly onto extended working lives. This session examines how financial institutions, insurers and policymakers are rethinking risk, product design and incentives to better align money, work and retirement with longer lifespans, exploring innovations that can support financial security, flexibility and resilience across a much longer life course.
Join the priority list to be first to hear about speakers, experiences and ticket releases, plus get 15% off Early Bird tickets.
You’re in.
Thanks for joining The Longevity Show community.
As a thank you, here’s 15% off your ticket:Code: WELCOME15
Use it at checkout and we’ll see you at Tobacco Dock.